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We have studied the interaction between monoclonal nti-trinitrophenyl antibodies (IgGl and IgG2a) and 
haptenated phospholipid vesicles using stopped-flow fluorometry. Conformational changes of the anti- 
bodies were induced very rapidly (within 0.1 s) after binding to lipid haptens (TNP-Cap-DPPE) on the mem- 
brane surfaces. Conversely, after that, the bound antibody molecules decreased the degree of molecular mo- 
tion at different depths in the bilayer, ranging from the polar head group to the terminal methyl groups 
of the fatty acyl chains. Such an effect reaches all places of the bilayer within 40 s at 25°C. 
Membrane fluidity Stopped-flow Liposome 
1. INTRODUCTION 
In recent years, biophysical and biochemical 
systems have provided us with a great deal of in- 
formation concerning properties of lipid bilayers. 
ESR, NMR and fluorescence polarization studies, 
for example, have been used to analyze dynamic 
motions (lateral diffusion and rotational motion) 
in lipid bilayers [l-4]. These methods have also 
been used to describe that a fluidity gradient exists 
along the acyl chain at different depths within the 
bilayers [l-4]. Such kinds of changes in membrane 
fluidity are considered to be very important for the 
process of recognition among cells of the immune 
system. To study such a problem, lipid vesicles 
containing specific antigens or lipid haptens have 
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Abbreviations: DMPC, dimyristoylphosphatidylcholine; 
DPPC, dipalmitoylphosphatidylcholine; PBS, phos- 
phate-buffered saline; TNP-Cap-DPPE, trinitrophenyl- 
aminocaproylphosphatidylethanolamine; SUV, single 
unilamellar vesicle; pyrene-DPPEA, N-( l-pyrenesulfo- 
nyl)dipalmitoyl-L-cy-phosphatidylethanolamine 
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been introduced and a number of interesting works 
have been done in this field [5-91. However, 
molecular properties of such membranes, after 
binding to antibodies or cells, have not been well 
defined yet [lo-121. 
Our aim is to describe our analysis of the change 
in membrane fluidity after binding to antibody 
molecules, using stopped-flow fluorometry. 
Monoclonal antibodies (IgGl and IgG2a) were 
found to have rapidly induced conformational 
changes after binding to lipid haptens on the mem- 
brane surfaces. Conversely, after that, the bound 
antibody molecule decreased the degree of 
molecular motion in the bilayer, depending on 
selected positions along the acyl chains. 
2. MATERIALS AND METHODS 
Monoclonal antibodies (IgGl and IgG2a) for a 
trinitrophenyl residue (TNP) were obtained from 
Dr M. Ueda (Kyoto University). Monoclonal an- 
tibodies were prepared as described by Kohler and 
Milstein [131. A lipid hapten (TNP-Cap-DPPE) 
was obtained from Dr T. Yasuda (University of 
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Tokyo). DMPC and DPPC were purchased from 
Sigma (St. Louis, MO). Three pyrene derivatives 
(1 -pyrenedodecanoic acid, 1 -pyrenedecanoic acid, 
1 -pyrenebutanoic acid) were purchased from 
Molecular Probe (Oregon). Pyrene-DPPEA was 
also from Molecular Probe. 
(4 IgGl 
SUVs were prepared by the injection of an 
ethanolic solution of a mixture of phospholipids 
(DMPC or DPPC) (99yo) and a TNP iipid hapten 
(1%) into a PBS solution at 70°C 114,151. Other 
SUVs for fluidity measurements were prepared 
from a mixture of a phospholipid (94.5010), a
pyrene derivative (5%) and a TNP lipid hapten 
(0.5%) by the same method. SUVs prepared were 
checked by their trapped umbelliferone phosphate 
1161. 
Cc) rabbit IgG 
Fluorescence spectra were observed with a 
Hitachi model 650-10s fluorescence spectrophoto- 
meter. Stopped-flow fluorescence measurements 
were taken with a Union Giken RA-401 stopped- 
flow spectrophotometer in combination with an 
RA-450 microcomputer [17]. We used a Hoya Y46 
cut filter (which allows only emitted light with 
wavelengths longer than 460 nm to enter the detec- 
tor) in fluorescence measurements. The dead time 
of this instrument is 0.5 ms. 
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Fig. 1. Stopped-flow fluorometric traces indicating 
conformational changes of IgGl and IgG2a after 
binding to haptens in the membranes, at 25°C; excited 
at 280 nm. Emitted light with wavelengths longer than 
300 nm was observed using a i-Ioya Y30 cut filter. (a) 
IgGl (8.8 x lo-’ M) in PBS was mixed with DMPC 
SUVs (4.6 x 10m6 M), containing 1% TNP-Cap-DPPE, 
in PBS. (b) IgG2a (1.4 x 10m6 M) in PBS was mixed with 
DMPC SUVs (5 x 10m6 M), containing 1% TNP-Cap- 
DPPE, in PBS. (c) Nonspecific rabbit IgG (2.0 x 
10T6 M) was mixed with DMPC SUVs (8.3 x 10m6 M), 
3. RESULTS containing 1% TNP-Cap-DPPE, in PBS. 
3.1. Antibody binding to the lipid hapten on the 
membrane 
fluorescence changes on TNP-labeled SUVs as 
shown in fig.lc. 
Fig. 1 shows the stopped-bow fluorometric 
traces when IgGl or IgG2a was mixed with a lipid 
hapten (TNP-Cap-DPPE) in the DMPC mem- 
brane. Antibody binding to the TNP haptens on 
the membrane surface reduced the tryptophan 
fluorescence intensity of these molecules. This is 
due to the fluorescence nergy transfer from tryp- 
tophan residues of antibodies to the bound TNP 
residues. The rate constants of these reactions were 
almost independent of the concentration of an- 
tibodies (3.5 x lo-‘-2.8 x 10T6 M). This indicates 
that the reactions observed here were due to the 
conformations changes of antibody molecules 
after binding to the haptens, and not to diffusion- 
controlled encounter complex formation. The rate 
constants of the conformational changes on the 
membrane were very similar (halflife 20 ms). 
Nonspecific rabbit IgGs did not cause any such 
3.2. Dependence of membrane fluidity on acyi 
chain length 
Fig.2 shows the fluorescence spectra of pyrene- 
loaded ‘fluid’ DMPC SUVs (containing 0.5% 
TNP-Cap-DPPE) in which the lateral diffusion 
coefficients of lipids are in the range of 
10-7-10-8 cm’/s [18]. The spectra for the 3 species 
of pyrene derivatives, which form excimers in fluid 
biological membranes, gave monomer fluores- 
cence peaks at 382 and 400 nm and a broad 
excimer fluorescence peak at 480 nm [19,20]. The 
intensity of excimer fluorescence in DMPC SUVs 
is in the following order: 1-pyrenedodecanoic acid 
> 1 -pyrenedecanoic acid > 1 -pyrenebutanoic acid. 
This difference is a direct reflection of the degree 
of molecular motion occurring at different depths 
in the bilayer, ranging from the polar head group 
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Fig.2. Fluorescence spectra of pyrene-loaded SUVs at 
25°C. SUVs contained DMPC (94.5%), a pyrene 
derivative (5%), and TNP-Cap-DPPE (6 x 10F8 M, 
0.5%). (-) Without antibodies, (---) with IgGZa. 
(a) SUV with I-pyrenedodecanoic acid. (b) SUV with 
I-pyrenedecanoic acid. (c) SUV with 1-pyrenebutanoic 
acid. 
to the terminal methyl groups of the fatty acyl 
chains [l-4]. Similar results were also obtained 
using ‘solid’ DPPC SUVs, labeled with the 3 dif- 
ferent pyrene derivatives, in which the lateral dif- 
fusion coefficients are of the order of lo-” cm2/s 
or less [18]. Thus, the excimer fluorescence 
described here is mostly due to the rapid flexing of 
acyl chains attached to the glycerol backbone of 
the phospholipid molecule or the rapid rotational 
diffusion about the long axis of the phospholipid, 
not due to the lateral movement of the 
phospholipid. 
3.3. Effect of antibody binding on membrane 
fluidity 
Fig.2 also illustrates the effect of the specific in- 
teraction of IgG2a with the TNP lipid hapten in 
membranes. The binding of IgG2a to the TNP 
residue caused a decrease in excimer fluorescence 
and an increase in monomer fluorescence of each 
pyrene derivative in membranes. These results 
reflect a decrease in membrane fluidity due to an- 
tibody binding. A control experiment with a 
nonspecific rabbit IgG showed no change in pyrene 
fluorescence. In the SUV sample labeled with 
1-pyrenebutanoic acid, there was very little change 
in monomer and excimer fluorescence after an- 
tibody binding because, the motion of this 
chromophore was very restricted even without an 
antibody. Similar results were obtained with 
DPPC SUVs, although the increase in monomer 
fluorescence and the decrease in excimer 
fluorescence were not as great as those seen with 
DMPC SUVs. Then, IgGl binding to SUVs gave 
results similar to those when IgG2a was used (not 
shown). 
3.4. Kinetics of the change of membrane fluidity 
The kinetics of the change of membrane fluidity 
as a result of the antibody-TNP interaction on 
DMPC SUVs were next examined by stopped-flow 
fluorometry. DMPC vesicles, which contained 
0.5% TNP-Cap-DPPE and 5% of a single pyrene 
derivative, were mixed with IgG2a. As can be seen 
in fig.3, there was a time-dependent decrease in ex- 
timer fluorescence intensity in SUVs with 
1 -pyrenedodecanoic acid and 1-pyrenedecanoic 
acid. Again, a control experiment with a 
nonspecific rabbit IgG showed no change in 
fluorescence intensity. 
The changes in excimer fluorescence were mostly 
first-order processes. The IgG2a binding reactions 
(halflives) are 5 s for 1-pyrenedodecanoic acid and 
1 s for 1-pyrenedecanoic acid at 25°C. These facts 
demonstrate that antibody binding reduces fluidity 
first in the outer parts of membranes and then such 
an effect is translated into the interior of the 
bilayers depending on acyl chain length. This was 
confirmed by the experiments using SUVs contain- 
ing pyrene-DPPEA. In these SUVs the pyrene 
moiety, which lies close to the polar head group 
and may be located on the surface of the bilayer, 
had a considerable excimer fluorescence and their 
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Fig.3. Stopped-flow fluorometric traces indicating the 
changes of membrane fluidity after antibody binding to 
SUVs at 25°C. SUVs contained DMPC (94.5%), a 
pyrene derivative (5%), and TNP-Cap-DPPE (6 x 
lOma M, 0.5%); excited at 340 nm. Emitted light with 
wavelengths longer than 460 nm was observed using a 
Hoya Y46 cut filter. (a) IgG2a (2.4 x lo-’ M) in PBS 
was mixed with SUV with 1-pyrenedodecanoic acid (6 x 
lo-’ M) in PBS. Nonspecific rabbit IgG showed no 
fluorescence change. (b) IgG2a (2.4 x lo-’ M) in PBS 
was mixed with SUV with I-pyrenedecanoic acid (6 x 
lo-’ M) in PBS. 
excimer fluorescence intensity was reduced too 
rapidly to be observed. 
4. DISCUSSION 
The present results demonstrate that the confor- 
mational changes of antibodies (IgGl and IgG2a) 
occurred very rapidly (0.1 s) after binding to lipid 
haptens on the membrane surfaces. Conversely, 
after that, the bound antibody molecules decreased 
membrane fluidity dependent on the position of 
the acyl chain length. The effect of antibody 
binding is observed more quickly at the surface of 
the membranes and then goes through the terminus 
of hydrocarbon chains. After 40 s the effect 
reaches all places of bilayer membranes at 25°C. 
It would be interesting to apply these findings to 
immunochemical systems on the membranes and 
determine whether antigen-antibody and ligand- 
receptor interactions cause a physical change in the 
cell membranes and whether such a physical 
change in the membrane can be correlated with a 
subsequent immune response. 
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